GlycoVaxyn and GlaxoSmithKline Biologicals(GSK)have signed a research partnership for the development of new bacterial vaccines. The collaboration,planned for three years,will leverage GlycoVaxyn's bio-conjugation technology in developing ...
Tags: GSK, Glycovaxyn, bacterial vaccines, Partnership